These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2472800

  • 1. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia.
    Tang HZ, Lu XF, Wang KJ, Ouyang S, Huang YQ.
    Mol Chem Neuropathol; 1989 Apr; 10(2):77-85. PubMed ID: 2472800
    [Abstract] [Full Text] [Related]

  • 2. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ, Lu XF, Wang KJ, Ou YS, Huang YQ.
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [Abstract] [Full Text] [Related]

  • 3. [The changes of monoamine metabolites in CSF of patients with cerebral stroke].
    Tang HZ.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):130-2, 186. PubMed ID: 1716195
    [Abstract] [Full Text] [Related]

  • 4. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T, Hara S, Kuriiwa F, Kano S.
    Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267
    [Abstract] [Full Text] [Related]

  • 5. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Jan; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 6. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG.
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD, Geracioti TD, Altemus M, Kling MA.
    Biol Psychiatry; 2018 May; 33(8-9):636-41. PubMed ID: 7687151
    [Abstract] [Full Text] [Related]

  • 8. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ, Bird ED, McEntee WJ.
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.
    Scheinin M, Chang WH, Kirk KL, Linnoila M.
    Anal Biochem; 1983 May; 131(1):246-53. PubMed ID: 6193730
    [Abstract] [Full Text] [Related]

  • 10. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K.
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [Abstract] [Full Text] [Related]

  • 11. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H, Lindquist C, Sedvall G.
    Acta Neurochir (Wien); 1985 Aug; 77(3-4):146-51. PubMed ID: 2416192
    [Abstract] [Full Text] [Related]

  • 12. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF, Waldmeier P, Beckmann H.
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [Abstract] [Full Text] [Related]

  • 13. Concentration gradient of CSF monoamine metabolites in children and adolescents.
    Kruesi MJ, Swedo SE, Hamburger SD, Potter WZ, Rapoport JL.
    Biol Psychiatry; 1988 Sep; 24(5):507-14. PubMed ID: 2458775
    [Abstract] [Full Text] [Related]

  • 14. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA, Bowden CL, Maas JW.
    J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E, Alling C, Andersch B, Andersson K, Berggren U.
    Neuropsychopharmacology; 1994 Nov 12; 11(3):201-13. PubMed ID: 7532413
    [Abstract] [Full Text] [Related]

  • 16. Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
    Hildebrand J, Bourgeois F, Buyse M, Przedborski S, Goldman S.
    Acta Neurol Scand; 1990 May 12; 81(5):427-30. PubMed ID: 1695809
    [Abstract] [Full Text] [Related]

  • 17. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 12; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 18. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM, Tsementzis SA, Wilson H.
    J Neurol Neurosurg Psychiatry; 1979 Oct 12; 42(10):887-91. PubMed ID: 512664
    [Abstract] [Full Text] [Related]

  • 19. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
    Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A.
    Alzheimer Dis Assoc Disord; 1989 Oct 12; 3(3):148-56. PubMed ID: 2477044
    [Abstract] [Full Text] [Related]

  • 20. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K.
    No To Shinkei; 1982 Nov 12; 34(11):1099-106. PubMed ID: 6186264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.